Robert Bersin
Cardiovascular Disease · Bellevue, WANPI 1033173836
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $435,400 of the $656,641 with a category attached, or 66.3%. Boston Scientific accounts for 80.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $529,139 and has fallen 99.9% since, to $300 in 2023. Among cardiovascular disease clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 394 payments — averaging $1666.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$530K
- Medtronic$113K
- Cardiovascular Systems Inc.$12K
- W. L. Gore & Associates, Inc.$623
- Silk Road Medical, Inc.$300
- Cook Medical LLC$102
Across 7 payments — averaging $2853.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Trireme Medical LLC$9K
- Endologix LLC$9K
- Bard Peripheral Vascular, Inc.$3K
What the payments were for
- Royalty or licence$46,2187%
- Consulting fees$17,9333%
- Speaking & faculty fees$435,40066%
- Travel & lodging$150,54823%
- Food & beverage$6,5411%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 344 | $530,421 |
| Medtronic | 41 | $112,944 |
| Cardiovascular Systems Inc. | 2 | $12,250 |
| W. L. Gore & Associates, Inc. | 5 | $623 |
| Silk Road Medical, Inc. | 1 | $300 |
| Cook Medical LLC | 1 | $102 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LOTUS EDGE$356,437
- GENERAL - THERAPIES$87,024
- GENERAL - STRUCTURAL HEART$67,841
- CoreValve Evolut$66,187
- VenaSeal$46,218
- Coronary Orbital Atherectomy System$12,250
- GENERAL VASCULAR ACCESS$7,347
- Watchman$4,598
- GENERAL VASCULAR INTERVENTION$2,471
- SPYGLASS$673
- ENROUTE Transcarotid Neuroprotection System$300
- ENROUTE Transcarotid Stent$300
- VIABAHN Endoprosthesis with Heparin Bioactive Surface$288
- GORE VIABAHN Endoprosthesis$143
- Cook Medical Stents$102
How this compares
$656,641 in reported general payments places this provider in the 95th percentile of 370 cardiovascular disease providers in Washington.
Other cardiovascular disease in Bellevue
- Thomas AmidonBellevue$64K
- Eugene YangBellevue$31K
- Adam ZivinBellevue$23K
- Craig TuohyBellevue$5K
- Ryan YuanBellevue$5K
- Ronnier AvilesBellevue$5K
- James WatsonBellevue$5K
- Mariko HarperSeattle$246K
- Gary OppenheimSeattle$153K
- Kelley BranchSeattle$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.